MarketScreener Strategies Eurofins Scientific SE
Equities
ERF
FR0014000MR3
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.92 EUR | -0.47% |
|
-1.83% | -5.61% |
| 12/05 | CAC 40: Luxury and Geopolitics Weigh on Sentiment |  |
| 11/05 | Eurofins among top CAC 40 decliners as BofA downgrades | |
MarketScreener Strategies
Search
 | Eurofins Scientific: 2026 targets confirmed despite a soft start; reasonable valuation outweighed by uncertainty | 24 April 2026 at 02:54 am AEST |
| Eurofins Scientific: Rolling over our model with reclassified EPS figures | 18 April 2026 at 10:36 pm AEST |
No results for this search
Filters
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition